A detailed history of Voya Investment Management LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 249,803 shares of DYN stock, worth $2.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
249,803
Previous 255,385 2.19%
Holding current value
$2.86 Million
Previous $9.17 Million 35.84%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$23.56 - $35.55 $131,511 - $198,440
-5,582 Reduced 2.19%
249,803 $5.89 Million
Q3 2024

Feb 07, 2025

SELL
$31.94 - $47.04 $159,125 - $234,353
-4,982 Reduced 1.91%
255,385 $9.17 Million
Q3 2024

Nov 14, 2024

SELL
$31.94 - $47.04 $188,988 - $278,335
-5,917 Reduced 2.33%
248,320 $8.92 Million
Q2 2024

Feb 07, 2025

BUY
$23.65 - $35.63 $4.34 Million - $6.54 Million
183,433 Added 238.43%
260,367 $9.19 Million
Q2 2024

Dec 03, 2024

BUY
$23.65 - $35.63 $139,937 - $210,822
5,917 Added 2.38%
254,237 $8.97 Million
Q2 2024

Aug 14, 2024

BUY
$23.65 - $35.63 $4.19 Million - $6.32 Million
177,303 Added 230.46%
254,237 $8.97 Million
Q1 2024

Feb 07, 2025

SELL
$13.06 - $29.18 $2.24 Million - $5 Million
-171,386 Reduced 69.02%
76,934 $2.18 Million
Q1 2024

Dec 06, 2024

SELL
$13.06 - $29.18 $2.24 Million - $5 Million
-171,386 Reduced 69.02%
76,934 $2.18 Million
Q1 2024

May 15, 2024

BUY
$13.06 - $29.18 $498,265 - $1.11 Million
38,152 Added 98.38%
76,934 $2.18 Million
Q4 2023

Feb 07, 2025

SELL
$6.62 - $13.64 $219,552 - $452,370
-33,165 Reduced 46.1%
38,782 $515,000
Q4 2023

Feb 14, 2024

SELL
$6.62 - $13.64 $219,552 - $452,370
-33,165 Reduced 46.1%
38,782 $515,000
Q3 2023

Feb 07, 2025

SELL
$8.6 - $12.18 $420,617 - $595,711
-48,909 Reduced 40.47%
71,947 $644,000
Q3 2023

Nov 14, 2023

SELL
$8.6 - $12.18 $420,617 - $595,711
-48,909 Reduced 40.47%
71,947 $644,000
Q2 2023

Feb 07, 2025

BUY
$8.53 - $14.28 $568,021 - $950,919
66,591 Added 122.71%
120,856 $1.36 Million
Q2 2023

Aug 14, 2023

BUY
$8.53 - $14.28 $568,021 - $950,919
66,591 Added 122.71%
120,856 $1.36 Million
Q1 2023

Feb 07, 2025

SELL
$10.88 - $15.0 $2.11 Million - $2.91 Million
-194,055 Reduced 78.15%
54,265 $625,000
Q1 2023

May 15, 2023

BUY
$10.88 - $15.0 $452,281 - $623,550
41,570 Added 327.45%
54,265 $625,000
Q3 2022

Feb 07, 2025

SELL
$7.2 - $15.17 $1.7 Million - $3.57 Million
-235,625 Reduced 94.89%
12,695 $161,000
Q3 2022

Nov 14, 2022

BUY
$7.2 - $15.17 $7,178 - $15,124
997 Added 8.52%
12,695 $161,000
Q4 2021

Feb 14, 2022

SELL
$11.89 - $16.07 $11 - $16
-1 Reduced 0.01%
11,698 $139,000
Q2 2021

Aug 16, 2021

BUY
$15.94 - $22.33 $186,482 - $261,238
11,699 New
11,699 $246,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $593M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.